PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma

por Naoya Maekawa, Satoru Konnai, Maki Nishimura, Yumiko Kagawa, Satoshi Takagi, Kenji Hosoya, Hiroshi Ohta, Sangho Kim, Tomohiro Okagawa, Yusuke Izumi, Tatsuya Deguchi, Yukinari Kato, Satoshi Yamamoto, Keiichi Yamamoto, Mikihiro Toda, Chie Nakajima, Yasuhiko Suzuki, Shiro Murata, Kazuhiko Ohashi
Publicado 2021

TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer

por Edaise M. da Silva, Pier Selenica, Mahsa Vahdatinia, Fresia Pareja, Arnaud Da Cruz Paula, Lorenzo Ferrando, Andrea M. Gazzo, Higinio Dopeso, Dara S. Ross, Ariya Bakhteri, Nadeem Riaz, Sarat Chandarlapaty, Pedram Razavi, Larry Norton, Hannah Y. Wen, Edi Brogi, Britta Weigelt, Hong Zhang, Jorge S. Reis-Filho
Publicado 2021

High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients

por Chao Liu, Kai Wang, Min Zhang, Xiaoyu Hu, Tian Hu, Yumei Liu, Qinyong Hu, Shikai Wu, Jinbo Yue
Publicado 2021

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer

por Lillian M. Smyth, Gerald Batist, Funda Meric-Bernstam, Peter Kabos, Iben Spanggaard, Ana Lluch, Komal Jhaveri, Andrea Varga, Andrea Wong, Alison M. Schram, Helen Ambrose, T. Hedley Carr, Elza C. de Bruin, Carolina Salinas-Souza, Andrew Foxley, Joana Hauser, Justin P. O. Lindemann, Rhiannon Maudsley, Robert McEwen, Michele Moschetta, Myria Nikolaou, Gaia Schiavon, Pedram Razavi, Udai Banerji, José Baselga, David M. Hyman, Sarat Chandarlapaty
Publicado 2021

Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®

por Richard Buus, Zsolt Szijgyarto, Eugene F. Schuster, Hui Xiao, Ben P. Haynes, Ivana Sestak, Jack Cuzick, Laia Paré, Elia Seguí, Nuria Chic, Aleix Prat, Mitch Dowsett, Maggie Chon U. Cheang
Publicado 2021

Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy

por Olga Martínez-Sáez, Tomás Pascual, Fara Brasó-Maristany, Nuria Chic, Blanca González-Farré, Esther Sanfeliu, Adela Rodríguez, Débora Martínez, Patricia Galván, Anna Belén Rodríguez, Francesco Schettini, Benedetta Conte, Maria Vidal, Barbara Adamo, Antoni Martínez, Montserrat Muñoz, Reinaldo Moreno, Patricia Villagrasa, Fernando Salvador, Eva M. Ciruelos, Iris Faull, Justin I. Odegaard, Aleix Prat
Publicado 2021

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer

por Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michal Marczyk, Courtney Frederick, Trisha Burrello, Eiman Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L. Rimm, Lajos Pusztai
Publicado 2021

A randomized intervention involving family to improve communication in breast cancer care

por Jennifer L. Wolff, Jennifer Aufill, Diane Echavarria, Amanda L. Blackford, Roisin M. Connolly, John H. Fetting, Danijela Jelovac, Katie Papathakis, Carol Riley, Vered Stearns, Nelli Zafman, Elissa Thorner, Howard P. Levy, Amy Guo, Sydney M. Dy, Antonio C. Wolff
Publicado 2021

Nobody dares stopping clinical research, not even COVID-19

por Andrea Malfettone, Serena Di Cosimo, José Manuel Pérez-García, Alicia García, Miguel Sampayo-Cordero, Leonardo Mina, Carolina Herrero, Antonio Llombart-Cussac, Javier Cortés
Publicado 2021

Genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma

por Matthew A. Wall, Serdar Turkarslan, Wei-Ju Wu, Samuel A. Danziger, David J. Reiss, Mike J. Mason, Andrew P. Dervan, Matthew W. B. Trotter, Douglas Bassett, Robert M. Hershberg, Adrián López García de Lomana, Alexander V. Ratushny, Nitin S. Baliga
Publicado 2021

Pathological Complete Response to Lenvatinib After Failure of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

por Yusuke Johira, Tomokazu Kawaoka, Masanari Kosaka, Yuki Shirane, Ryoichi Miura, Serami Murakami, Shigeki Yano, Kei Amioka, Kensuke Naruto, Yuwa Ando, Yumi Kosaka, Kenichiro Kodama, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Wataru Okamoto, Masami Yamauchi, Michio Imamura, Kazuhiro Sentani, Naohide Oue, Koji Arihiro, Shintaro Kuroda, Tsuyoshi Kobayashi, Hideki Ohdan, Kazuaki Chayama, Hiroshi Aikata
Publicado 2021

Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations

por Neil M. Iyengar, Xi Kathy Zhou, Hillary Mendieta, Omar El-Hely, Dilip D. Giri, Lisle Winston, Domenick J. Falcone, Hanhan Wang, Lingsong Meng, Taehoon Ha, Michael Pollak, Monica Morrow, Andrew J. Dannenberg
Publicado 2021

Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment

por Julia Stevenson, Rachel Barrow-McGee, Lu Yu, Angela Paul, David Mansfield, Julie Owen, Natalie Woodman, Rachael Natrajan, Syed Haider, Cheryl Gillett, Andrew Tutt, Sarah E. Pinder, Jyoti Choudary, Kalnisha Naidoo
Publicado 2021

The human intermediate prolactin receptor is a mammary proto-oncogene

por Jacqueline M. Grible, Patricija Zot, Amy L. Olex, Shannon E. Hedrick, J. Chuck Harrell, Alicia E. Woock, Michael O. Idowu, Charles V. Clevenger
Publicado 2021

Preoperative immune landscape predisposes adverse outcomes in hepatocellular carcinoma patients with liver transplantation

por Sang-Ho Yoon, Seo-Won Choi, Suk Woo Nam, Kyoung Bun Lee, Jin-Wu Nam
Publicado 2021

Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score

por Soonmyung Paik, Youngmee Kwon, Moo Hyun Lee, Ji Ye Kim, Da Kyung Lee, Won Jeong Cho, Eun Young Lee, Eun Sook Lee
Publicado 2021

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer

por Gaia Griguolo, Maria Vittoria Dieci, Laia Paré, Federica Miglietta, Daniele Giulio Generali, Antonio Frassoldati, Luigi Cavanna, Giancarlo Bisagni, Federico Piacentini, Enrico Tagliafico, Katia Cagossi, Guido Ficarra, Aleix Prat, Pierfranco Conte, Valentina Guarneri
Publicado 2021

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease

por Francisco Beca, Hannah Oh, Laura C. Collins, Rulla M. Tamimi, Stuart J. Schnitt
Publicado 2021

Dynamic roles of inflammasomes in inflammatory tumor microenvironment

por Jeong-Hoon Jang, Do-Hee Kim, Young-Joon Surh
Publicado 2021

Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature

por Kyrgias G, Theodorou K, Zygogianni A, Tsanadis K, Zervoudis S, Tzitzikas, Koukourakis M
Publicado 2012